Gene · 771
Papers1,772
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,772
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Co-cultures of colon cancer cells and cancer-associated fibroblasts recapitulate the aggressive features of mesenchymal-like colon cancer. | Front Immunol | 2023 | 37261365 | PubTator, text mining | PubMed |
| Pyrrolyl and Indolyl α-γ-Diketo Acid Derivatives Acting as Selective Inhibitors of Human Carbonic Anhydrases IX and XII. | Pharmaceuticals (Basel) | 2023 | 37259337 | PubTator, text mining | PubMed |
| MicroRNA-372 acts as a double-edged sword in human cancers. | Heliyon | 2023 | 37251909 | PubTator, text mining | PubMed |
| An estrogen response-related signature predicts response to immunotherapy in melanoma. | Front Immunol | 2023 | 37251404 | PubTator, text mining | PubMed |
| Uncovering Novel Capsaicin Inhibitory Activity towards Human Carbonic Anhydrase Isoforms IX and XII by Combining In Silico and In Vitro Studies. | Antioxidants (Basel) | 2023 | 37237982 | PubTator, text mining | PubMed |
| Unraveling the Antioxidant Capacity of Spatholobi caulis in Nonalcoholic Fatty Liver Disease: A Multiscale Network Approach Integrated with Experimental Validation. | Antioxidants (Basel) | 2023 | 37237962 | PubTator, text mining | PubMed |
| Multisite Labeling of Proteins Using the Ligand-Directed Reactivity of Triggerable Michael Acceptors. | Bioconjug Chem | 2023 | 37220065 | PubTator, text mining | PubMed |
| Current Advances in the Treatment of Fibrolamellar Carcinoma of Liver. | J Hepatocell Carcinoma | 2023 | 37215364 | PubTator, text mining | PubMed |
| Recent advances in synthetic strategies and SAR of thiazolidin-4-one containing molecules in cancer therapeutics. | Cancer Metastasis Rev | 2023 | 37204562 | PubTator, text mining | PubMed |
| Revealing platelet-related subtypes and prognostic signature in pancreatic adenocarcinoma. | BMC Med Genomics | 2023 | 37198621 | PubTator, text mining | PubMed |
| Discovery of Diverse CRISPR-Cas Systems and Expansion of the Genome Engineering Toolbox. | Biochemistry | 2023 | 37192099 | PubTator, text mining | PubMed |
| Inflammation as a Regulator of the Airway Surface Liquid pH in Cystic Fibrosis. | Cells | 2023 | 37190013 | PubTator, text mining | PubMed |
| Differential Activation of NRF2 Signaling Pathway in Renal-Cell Carcinoma Caki Cell Lines. | Biomedicines | 2023 | 37189628 | PubTator, text mining | PubMed |
| Organoid models of fibrolamellar carcinoma mutations reveal hepatocyte transdifferentiation through cooperative BAP1 and PRKAR2A loss. | Nat Commun | 2023 | 37137901 | PubTator, text mining | PubMed |
| Discovery of sulfonamide-tethered isatin derivatives as novel anticancer agents and VEGFR-2 inhibitors. | J Enzyme Inhib Med Chem | 2023 | 37122176 | PubTator, text mining | PubMed |
| Carbonic Anhydrases: A Superfamily of Ubiquitous Enzymes. | Int J Mol Sci | 2023 | 37108175 | PubTator, text mining | PubMed |
| Carbonic anhydrases reduce the acidity of the tumor microenvironment, promote immune infiltration, decelerate tumor growth, and improve survival in ErbB2/HER2-enriched breast cancer. | Breast Cancer Res | 2023 | 37098526 | PubTator, text mining | PubMed |
| Identification of a gene expression signature associated with breast cancer survival and risk that improves clinical genomic platforms. | Bioinform Adv | 2023 | 37096121 | PubTator, text mining | PubMed |
| Identification of gene signatures related to hypoxia and angiogenesis in pancreatic cancer to aid immunotherapy and prognosis. | Front Oncol | 2023 | 37064125 | PubTator, text mining | PubMed |
| CEBPD is a master transcriptional factor for hypoxia regulated proteins in glioblastoma and augments hypoxia induced invasion through extracellular matrix-integrin mediated EGFR/PI3K pathway. | Cell Death Dis | 2023 | 37059730 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/771/papers?page=11